1Qinbo XU,Schett G,Persehinka H,et al.Serum soluble heat shook protein 60 is elevated in subjects with athemsclerosis in a general population.Circulation,2000,102.14-20.
2Mandal K,Jahangiri M,Xu Q.Autoimmunity to heat shock protein in atherosclerosis.Autoimmun Rev,2004,3:31-37.
3Hauet-Broere F,Wieten L,Guichelaar T.Heat shock proteins induce T cell regulation of chronic inflammation,Ann Rheum Dis,2006,65(Suppl 3):65-68.
5Julian PJ,Deanfield HJ.Circulating human heat shock protein 60 in the blood of healthy teenagers:a novel determinant of endothelial dysfunction and early vascular injury.Arterioscler Thromb Vase Biol,2005,25:141-142.
2Qinbo xu,Geir schett,Hannes Perschinka,et al.Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population[J].Circulation,2000,102:14-20.
3Kol A,Bourcier T,Lichtman A,et al.Chlamydial and human heat shock protein 60s activate human vascular endothelium,smooth muscle cells,and macrophage[J].J clin Invest,1999,103:571-577.
4Kol A,Sukhova GK,Lichtman AH,et al.Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression[J].Circulation,1998,98:300-307.
5Jo Lewthwaite,Natalite Owen,Anthony Coates,et al.Circulating human heat shock protein 60 in the plasma British civil servants relation to physiological psychosocial stress[J].Circulation,2002,106:196-201.
6Kleindienst R,Xu Q,Willeit J,et al.Immunology of atherosclerosis:demonstration of hsp60 expression and T lympocytes bearingαβ or γδ recptor in human atherosclerotic lesions[J].Am J Path,1993,142:1927-1937.
7Liao D-F,Jin Z-G,Baas AS,et al.Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells[J].J Biol Chem,2000,275:189-196.
8Schett G,Xu Q,Amberger A,et al.Autoantibodies against heat shock protein mediate endothelia cytotoxicity[J].J Clin Invest,1995,96:2569-2577.
9Sawchuk AP,Unthank JL,Davis TE,et al.A prospective,in vivo study of the relationship between blood flow haemodynamics and atherosclerosis in a hyperlipidemic swine model[J].J vasc Surg,1994,19:58-63.
3Braunwald E. Unstable angina: an etiology approach to management[J]. Circulation, 1998, 98 (21) :2219 - 2222.
4ACC/AHA Guidelines for the management of patients with unstable angina and no - ST - segment elevation myocardi - al infarction: A report of American collage of cardiology/ American heart association task force or practice guide - lines [J]. J Am Coll Cardio, 2000, 36(8): 970 - 1062.
5Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of etalloproteinases: structure, function, and biochemistry[J]. Circ Res, 2003, 92(7): 827 - 839.
6Kalela A, Koivu TA, Sisto T, et al. Serum matrix metalloproteinase - 9 concentration in angiographically assessed coronary artery disease[J] . Stand J Clin Lab Invest, 2002, 62(4): 337 - 342.
7Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinase- 9 and tissue inhibitor of metalloproteinase - 1 are increased in the coronary circulation in patients with acute coronary syndrome[J]. Am Heart J, 2001, 141 (2): 211 -217.
8Tsan MF, Gao B. Cytokine function of heart shock proteins[J]. Am J Physical Cell Physio1,2004, 286(6):739 -744.
9Zal B, Kaski JC, Arno G, et al. Heat - shock protein 60 - reactive CD4^+ CD28 null T cells in patients with acute coronary syndromes [ J ]. Circulation, 2004, 109 (10) : 1230 - 1235.
10Liao D -F,Jin Z -G,Baas AS,et al. Purification and identification of secreted oxidative stress - induced factors from vascular smooth mus- clecells[ J]. J Biol Chem,2000,275 : 189 - 196.
